Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Actelion Pharmaceuticals Ltd patents


Recent patent applications related to Actelion Pharmaceuticals Ltd. Actelion Pharmaceuticals Ltd is listed as an Agent/Assignee. Note: Actelion Pharmaceuticals Ltd may have other listings under different names/spellings. We're not affiliated with Actelion Pharmaceuticals Ltd, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "A" | Actelion Pharmaceuticals Ltd-related inventors


Crystalline forms of cadazolid

. . The present invention relates to crystalline forms of cadazolid.. . ... Actelion Pharmaceuticals Ltd

Therapeutic compositions

. . The invention relates to a product containing the compound of formula (i) below (i) or a pharmaceutically acceptable salt of this compound, in combination with at least one compound having pde5-inhibitory properties, or a pharmaceutically acceptable salt thereof, for therapeutic use, simultaneously, separately or over a period of time, in the treatment of a disease wherein vasoconstriction is involved.. . ... Actelion Pharmaceuticals Ltd

Methods for treating skin disorders with a topical composition of bis-(2-chloroethyl)methylamine

Provided are methods for treating skin disorders comprising topically applying a highly stable pharmaceutical composition comprising bis-(2-chloroethyl)methylamine or a pharmaceutically acceptable salt thereof.. . ... Actelion Pharmaceuticals Ltd

Crystalline salt form of (s)-(2-(6-chloro-7-methyl-1h-benzo[d]imidazol-2-yl)-2-methylpyrrolidin-1-yl)(5-methoxy-2-(2h-1,2,3-triazol-2-yl)phenyl)methanone as orexin receptor antagonist

The invention relates to a crystalline form of (s)-(2-(6-chloro-7-methyl-1h-benzo[d]imidazol-2-yl)-2-methylpyrrolidin-1-yl)(5-methoxy-2-(2h-1,2,3-triazol-2-yl)phenyl)methanone hydrochloride, processes for the preparation thereof, pharmaceutical compositions containing said crystalline form, and its use as medicament, especially as orexin receptor antagonist.. . ... Actelion Pharmaceuticals Ltd

Pharmaceutical combination comprising a selective s1p1 receptor agonist

. . The present invention relates to a pharmaceutical combination comprising a first active ingredient which is (r)-5-[3-chloro-4-(2,3-dihydroxy-propoxy)-benz[z]ylidene]-2-([z]propylimino)-3-o-tolyl-thiazolidin-4-one or a pharmaceutically acceptable salt thereof and a second active ingredient which is selected from the group consisting of methyl fumarate, dimethyl fumarate, (n,n-diethylcarbamoyl)methyl methyl (2e)but-2-ene-1,4-dioate, and 2-(2,5-dioxopyrrolidin-1-yl)ethyl methyl (2e)but-2-ene-1,4-dioate, or a pharmaceutically acceptable salt thereof.. . ... Actelion Pharmaceuticals Ltd

Dosing regimen for a selective s1p1 receptor agonist

. . The present invention relates to a dosing regimen for (r)-5-[3-chloro-4-(2,3-dihydroxy-propoxy)-benz[z]ylidene]-2-([z]-propylimino)-3-o-tolyl-thiazolidin-4-one.. . ... Actelion Pharmaceuticals Ltd

8-(piperazin-1-yl)-1,2,3,4-tetrahydro-isoquinoline derivatives

. . . . . . The invention relates to compounds of formula (i) wherein r1, r2, r3, r4 and r5 are as described in the description; to pharmaceutically acceptable salts thereof, and to the use of such compounds as medicaments, especially as modulators of the cxcr3 receptor.. . ... Actelion Pharmaceuticals Ltd

Use of benzimidazole-proline derivatives

. . . . . . . . The present invention relates to compounds of the formula (i), wherein ar1 and ar2 are as described in the description and to their use as pharmaceuticals for the treatment of sundown syndrome. The invention also relates to the preparation of such compounds and of pharmaceutically acceptable salts thereof.. ... Actelion Pharmaceuticals Ltd








ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Actelion Pharmaceuticals Ltd in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Actelion Pharmaceuticals Ltd with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###